Menu

Abeona Therapeutics Inc. ABEO

Full chart Compare
Set alert

Price alert · ABEO

All alert types
4.17 USD +0.26 (+6.65%)

At closeNov 6, 2026, 4:07 PM EST

4.18 +0.01 +0.23%

After hours · Nov 6, 4:07 PM ET

3.95 Day range 4.26
3.91 52-week range 7.46
YTD
-20.87%
1 year
-0.48%

Revenue & Expenses

Revenue by
Other Income → Gross Profit & Other Income: $160.73MGross Profit & Other Income → Net Income: $71.18MGross Profit & Other Income → Selling, General & Admin: $65.03MGross Profit & Other Income → Research & Development: $26.81MGross Profit & Other Income → Other Operating Expenses: $1.89MGross Profit & Other Income → Income Tax: $100.00KLicense → Revenue: $3.40MGross Profit → Gross Profit & Other Income: $4.29MRevenue → Gross Profit: $4.29MRevenue → Cost of Revenue: $1.53MProduct → Revenue: $2.42MOther Income$160.73MGross Profit$4.29MCost of Revenue$1.53MGross Profit & Other Income$165.02MNet Income$71.18MSelling, General & Admin$65.03MResearch & Development$26.81MOther Operating Expenses$1.89MIncome Tax$100.00KRevenue$5.82MLicense$3.40MProduct$2.42M

Latest period ending Dec 31, 2025 · select a line to chart its full history

ABEO annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
5.82M03.50M1.41M3.00M
4.29M03.50M1.41M3.00M
-87.56M-64.21M-45.53M-50.47M-89.84M
71.18M-63.73M-54.19M-39.70M-84.94M
1.01-1.55-2.53-5.53-21.57
ABEO annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
78.44M23.70M14.81M14.55M38.83M
219.57M108.93M64.00M64.21M79.59M
60.35M64.90M49.18M37.45M37.22M
24.97M23.05M5.40M7.63M9.38M
159.22M44.03M14.83M26.76M42.37M
ABEO annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-76.33M-56.02M-37.01M-43.48M-65.67M
105.03M-39.24M208.00K-23.96M66.06M
26.04M104.14M37.06M43.17M24.86M
-7.97M-2.43M-127.00K1.60M-4.15M
54.74M8.88M256.00K-24.27M25.26M